Clinical Trials Logo
  1. Home
  2. Outcome, Fatal
  3. NCT04339322
  4. Details
NCT04339322 Clinical Trial

Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt

Outcome, Fatal Clinical Trial

— COVID-19  

Official title:
Characteristics and Outcome of COVID-19 Among Egyptian Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04339322
Other study ID # COVID-19 in Egypt
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 1, 2020
Est. completion date July 30, 2020

Study information
Verified date April 2020
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The World Health Organization (WHO) has recently declared coronavirus disease 2019 (Covid-19) a public health emergency of international concern. Egypt is one of the countries that has been infected by Covid-19. The characteristics of clinical presentation, laboratory and radiological data are not yet studied. Outcomes of covid-19 in Egypt also have not been described yet.

Description:

Patients admitted to Assiut University hospital, Al Rajhi liver hospital and other covid-19 Quarantine hospitals will be included. The characteristics of patients will be described such as demographic data; age, sex,history of contact to COVID-19 patients or traveling abroad and their clinical manifestation such as fever,cough,shortness of breath, sore throat, diarrhea. Laboratory data will also be included such as blood picture,D-Dimer, serum ferritin, creatinine, liver enzymes, oxygen saturation and covid-19 polymerase chain reaction (PCR). Radiological data will be described as regarding chest X-ray and/or computed tomography.

Patients will be followed until complications, improvement, transfer to another hospital or death and their outcome will be described.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 200
Est. completion date July 30, 2020
Est. primary completion date July 30, 2020
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients with diagnosis of Covid-19 .

Exclusion Criteria:

- Patients refuse to participate in the study

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Follow up
Follow up to assess the outcome until complications, improvement, death or being transferred to another quarantine hospital.

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Assiut University

Outcome
Type Measure Description Time frame Safety issue
Primary Demographics of Coronavirus Disease 2019 (COVID-19) in the cohort group Sheet recording age, sex, co-morbidity,history of contact 2 months
Primary Clinical manifestations of Coronavirus Disease 2019 (COVID-19) Sheet recording symptoms and signs 2 month
Primary Laboratory data of included Coronavirus Disease 2019 (COVID-19) cohort blood picture,D-Dimer, creatinine, liver enzymes 2 months
Primary Radiological features of Coronavirus Disease 2019 (COVID-19) cohort Chest x-ray and/or Computed tomography 2 month
Secondary outcomes of Coronavirus Disease 2019 (COVID-19) infection in the cohort group Data recording of the outcomes of treatment 1 week
See also
  Status Clinical Trial Phase
Completed NCT04735055 - Artificial Intelligence Prediction for the Severity of Acute Pancreatitis
Recruiting NCT06006975 - Early Warning of Delayed Cerebral Ischemia
Not yet recruiting NCT05983549 - Neutral Versus Liberal fLuId In Traumatic Brain Injury: a Randomised Controlled Trial N/A
Recruiting NCT05788861 - Invasive Group A Streptococcal Infection
Completed NCT03104946 - To Research the Relation Between Neonatal Morbidities and Poor Outcome in Preterm Infants N/A
Not yet recruiting NCT04584463 - Factors Associated With CPC 1-2 in 110 Patients Admitted in French ICU for a Myocardial Infarction Complicated by an OHCA.
Completed NCT04235920 - Cognitive Impairment and Outcome of Acute Ischemic Stroke.
Not yet recruiting NCT04582188 - The Early Coagulopathy for the Prognosis in Sepsis
Completed NCT04260334 - Preoperative Care In Ovarian Cancer Patients N/A
Recruiting NCT04121429 - Stopping Cardiovascular Treatments and Mortality in a MICU
Completed NCT05338593 - Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.
Completed NCT03619759 - The Effect of Sugammadex on the Outcome After Colorectal Cancer Surgery
Not yet recruiting NCT06146270 - Russian Registry of Surgical OutcomeS
Completed NCT04542954 - Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East
Withdrawn NCT03228043 - Apatinib for Resectable Colorectal Cancer N/A
Completed NCT04292964 - Prognostic Factors of Patients With COVID-19
Completed NCT03470571 - CMR Features in Patients With Suspected Myocarditis
Active, not recruiting NCT04293653 - Protocol for Patients Above 75 Years Undergoing Emergency Laparotomy N/A
Not yet recruiting NCT04683458 - Analysis of Linked Health Insurance Claims and Clinical Registries to Determine Device Surveillance With Paclitaxel-coated Medical Devices
Completed NCT02947698 - Effect of Weekend Admission on Mortality Associated With Severe Acute Kidney Injury in England: a Propensity Score Matched, Population-based Study N/A